Brief: Theradiag Announces Agreement With Predictimmune For Commercialization Of PredictSURE IBD™
28/10/2019 17:22
Oct 28 (Reuters) - Theradiag SA ALTHE.PA :
* THERADIAG AND PREDICTIMMUNE ANNOUNCE A STRATEGIC AGREEMENT
FRENCH SPEAKING EUROPE TO COMMERCIALISE PREDICTSURE IBD™, THE
WORLD’S FIRST VALIDATED PROGNOSTIC TEST FOR INFLAMMATORY BOWEL
DISEASE
Source text for Eikon: ID:nNDL82cJbm
Further company coverage: ALTHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))